Abstract Library

#3018 Real-Life Data for Telotristat Ethyl in Resistant-to-Treatment Carcinoid Syndrome: Is It Efficacious in Carcinoid Flushing as Well?

Introduction: Results from clinical trials with telotristat ethyl (TE) are really encouraging about its role in carcinoid syndrome-associated diarrhoea, however, its efficacy in flushing has been equivocal.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Gertner J

Authors: Gertner J, Eastwood O, Furtado O'Mahony L, Quaglia E, McSweeney A,

Keywords: telotristat,

#2818 Is It That Rare?

Introduction: Carcinoid heart disease (CHD) is a rare and unique manifestation, It present in 50% of CS

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Babli S

Authors: Babli S, Alzahrani W, Aldawish M,

Keywords: neuroendocrine tumors, carcinoid syndrome, carcinoid heart disease,

#2701 Assessing the Gaps in Experience and Knowledge of Australian Primary Health Care Professionals (GPs), in Treating and Caring for the Increasing Number of Australian Neuroendocrine Tumour (NET) Patients

Introduction: Conservatively,the incidence of NETs is 7 / 000' p.a, however,the prevalence of patients living with NETs is higher,40/000',making it the 2nd most common GI malignancy after colorectal cancer.Patients are living longer,however,with impaired quality of life.Management of debilitating symptoms such as diarrhoea,fatigue,anxiety,and flushing are complex and heterogenous.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Leyden S

Authors: Leyden S, Cummins M, Wakelin K,

Keywords: diagnosis, ongoing care, primary healthcare, NETs, quality of life, symptom management, NET symptoms,

#2063 Interim Analyses LANREL07484: Response to Treatment and Self-Reported Satisfaction in Symtoms in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Lanreotide Autogel in South Africa

Introduction: An ongoing South African observational study in patients with symptomatic gastroenteropancreatic neuroendocrine tumours (GEP-NET)

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Geldenhuys D

Authors: Geldenhuys D, Jacobs C, Rapoport B, Fourie S, Szpak W,

Keywords: gastroenteropancreatic neuroendocrine tumors, Flushing, Diarrhoea, Lanreotide Autogel,

#2062 Interim Analyses LANREL07484: Quality of Life in Patients with Symptomatic Gastroenteropancreatic Neuroendocrine Tumors Treated with Lanreotide Autogel in South Africa

Introduction: LANRELO7484 is an ongoing, observational study in patients with symptomatic gastroenteropancreatic neuroendocrine tumours (GEP-NET) in South Africa (SA).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Geldenhuys D

Authors: Geldenhuys D, Jacobs C, Rapoport B, Fourie S, Szpak W,

Keywords: Gastroenteropancreatic Neuroendocrine Tumors, Quality of Life,